-
摘要: 青年女性患者,16岁,主因胸闷、头痛4 d入院,入院当天胸闷加重,活动耐量下降,并出现胸痛,心电图为aVR导联抬高,其余导联均显著压低。心脏彩超提示左室壁运动弥漫性减低。化验患者氧分压降低,肌钙蛋白、C反应蛋白、D二聚体定量、血沉均升高。冠脉造影提示左主干病变,于病变处植入1枚支架。后续完善检查,全身大动脉CT血管造影(computed tomography angiography,CTA)显示肺动脉、肾动脉多处弥漫性管壁增厚、狭窄。患者符合大动脉炎诊断,给予激素+免疫抑制剂+托珠单抗治疗大动脉炎及冠脉介入后抗血小板、抗凝、抑制心室重塑、利尿减轻心脏负荷、抑酸护胃等综合治疗,患者病情好转出院。5个月随访患者无不适症状发作,心功能恢复,病情平稳。Abstract: The patient, a 16-year-old young female, was admitted to the hospital mainly due to chest tightness and headache for 4 days. On the day of admission, the chest tightness worsened, activity tolerance decreased, and chest pain occurred. The electrocardiogram showed elevated aVR leads, and other leads were significantly depressed. Color echocardiography showed reduced diffusion of left ventricular wall motion. Oxygen partial pressure decreased, troponin, C-reactive protein, D dimer quantification, erythrocyte sedimentation rate increased. Coronary angiography indicated left main lesion, and a stent was implanted. Computed tomography angiography(CTA) showed diffuse wall thickening and stenosis in pulmonary and renal arteries. The patient was diagnosed with Takayasu arteritis, and prescribed hormone, immunosuppressant and tozimumab and a comprehensive treatment of anti-platelet, anticoagulation, inhibition of ventricular remodeling, diuresis to reduce cardiac load after coronary intervention. The patient recovered well in follow-up of 5 months.
-
Key words:
- Takayasu arteritis /
- left main lesion /
- young female
-
[1] Pedreira AL, Santiago MB. Association between Takayasu arteritis and latent or active Mycobacterium tuberculosis infection: a systematic review[J]. Clin Rheumatol, 2020, 39(4): 1019-1026. doi: 10.1007/s10067-019-04818-5
[2] Keser G, Aksu K, Direskeneli H. Takayasu arteritis: an update[J]. Turk J Med Sci, 2018, 48(4): 681-697. doi: 10.3906/sag-1804-136
[3] Yang Y, Tian T, Yang K, et al. Outcomes of percutaneous coronary intervention and coronary artery bypass grafting in patients with Takayasu arteritis[J]. Int J Cardiol, 2017, 241(8): 64.
[4] 叶亮, 孙丽华, 谷伟, 等. 以间质性肺炎为首诊的多发性大动脉炎一例[J]. 中华结核和呼吸杂志, 2020, 43(4): 369-370.
[5] 耿明慧, 张伟, 林海霞, 等. 广泛型大动脉炎伴双肾动脉狭窄并发心力衰竭1例[J]. 临床心血管病杂志, 2022, 38(5): 423-426. https://lcxxg.whuhzzs.com/article/doi/10.13201/j.issn.1001-1439.2022.05.017
[6] Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis[J]. Arthritis Rheum, 1990, 33: 1129-1134.
[7] Saadoun D, Vautier M, Cacoub P. Medium-and large-vessel vasculitis[J]. Circulation, 2021, 143(3): 267-282. doi: 10.1161/CIRCULATIONAHA.120.046657
[8] Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of giant cell arteritis and Takayasu arteritis[J]. Arthritis Rheumatol, 2021, 73(8): 1349-1365. doi: 10.1002/art.41774
[9] 陈敏, 高洁, 牛慧敏, 等. SMI评估多发性大动脉炎颈动脉增厚管壁内新生血管治疗前后的变化[J]. 临床心血管病杂志, 2021, 37(2): 161-166. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB202102015.htm
[10] 王蕊, 张极峰, 李萍. 18F-FDG PET/CT在多发性大动脉炎应用中的研究进展[J]. 中国中西医结合影像学杂志, 2022, 20(1): 85-88. https://www.cnki.com.cn/Article/CJFDTOTAL-JHYX202201021.htm